Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Health Direction, Teaching Hospital, University of Campania "Luigi Vanvitelli", Naples, Italy.
Expert Rev Vaccines. 2021 Jul;20(7):881-889. doi: 10.1080/14760584.2021.1922081. Epub 2021 May 25.
Understanding healthcare workers (HCWs) willingness to receive a future vaccination against coronavirus disease 2019 (COVID-19) may be useful.
Cross-sectional study, conducted in Italy from September 14 to November 30, 2020, among 811 HCWs who undergo a voluntary antibody-testing for anti-SARS-CoV-2.
The perceived risk level of developing COVID-19, measured on a Likert-type scale ranging from 1 to 10, was 6.6 and it was higher among females, older HCWs, and in those who agreed that COVID-19 is a severe disease. Married/cohabitant, not physicians, and those who needed additional information regarding the vaccination against COVID-19 were more likely to be concerned that COVID-19 vaccination might not be safe. Males, physicians, those who did not have had any symptom compatible with COVID-19, those who agreed that COVID-19 is a severe disease, those who perceived to be at higher risk of developing COVID-19, those who were not concerned about the vaccine's safety, and those who had received information regarding the COVID-19 vaccination from scientific journals expressed willingness to receive vaccination against COVID-19.
Communication and education targeted to groups with lowest willingness are needed to raise awareness regarding the safety and benefits of the vaccination and to improve vaccine uptake.
了解医护人员(HCWs)对接种未来的 2019 年冠状病毒病(COVID-19)疫苗的意愿可能是有用的。
横断面研究,于 2020 年 9 月 14 日至 11 月 30 日在意大利进行,研究对象为 811 名接受 SARS-CoV-2 抗体自愿检测的 HCWs。
COVID-19 发病风险感知水平,以 1 到 10 的李克特量表衡量,为 6.6,女性、年龄较大的 HCWs 以及认为 COVID-19 是一种严重疾病的 HCWs 中更高。已婚/同居、非医师,以及那些需要有关 COVID-19 疫苗接种的更多信息的 HCWs,更担心 COVID-19 疫苗接种可能不安全。男性、医师、没有任何与 COVID-19 相符的症状的 HCWs、认为 COVID-19 是一种严重疾病的 HCWs、认为自己有更高 COVID-19 发病风险的 HCWs、不担心疫苗安全性的 HCWs,以及那些从科学期刊获得 COVID-19 疫苗接种信息的 HCWs,均表示愿意接种 COVID-19 疫苗。
需要针对意愿最低的群体进行沟通和教育,以提高对疫苗安全性和益处的认识,并提高疫苗接种率。